Glucotoxicity in the INS-1 Rat Insulinoma Cell Line Is Mediated by the Orphan Nuclear Receptor Small Heterodimer Partner
- Keun-Gyu Park1,
- Kyeong-Min Lee2,
- Hye-Young Seo2,
- Ji-Ho Suh3,
- Hye-Soon Kim1,
- Li Wang4,
- Kyu-Chang Won5,
- Hyoung-Woo Lee5,
- Joong-Yeol Park6,
- Ki-Up Lee6,
- Jung-Guk Kim2,
- Bo-Wan Kim2,
- Hueng-Sik Choi3 and
- In-Kyu Lee2
- 1Department of Internal Medicine, Keimyung University School of Medicine, Daegu, Republic of Korea
- 2Department of Internal Medicine, and Biochemistry and Cell Biology, Kyungpook National University School of Medicine, Daegu, Republic of Korea
- 3Hormone Research Center, School of Biological Sciences and Technology, Chonnam National University, Kwangju, Republic of Korea
- 4Departments of Medicine and Pharmacology, University of Kansas Medical Center, Kansas
- 5Department of Internal Medicine, Yeungnam University College of Medicine, Daegu, Republic of Korea
- 6Department of Internal Medicine, University of Ulsan College of Medicine, Seoul, Republic of Korea
- Address correspondence and reprint requests to In-Kyu Lee, MD, PhD, Department of Internal Medicine, Kyungpook National University Hospital, 50 Samduk-2ga, Jung-gu, Daegu, 700-721, Republic of Korea. E-mail: leei{at}knu.ac.kr
Abstract
Prolonged elevations of glucose concentration have deleterious effects on β-cell function. One of the hallmarks of such glucotoxicity is a reduction in insulin gene expression, resulting from decreased insulin promoter activity. Small heterodimer partner (SHP; NR0B2) is an atypical orphan nuclear receptor that inhibits nuclear receptor signaling in diverse metabolic pathways. In this study, we found that sustained culture of INS-1 cells at high glucose concentrations leads to an increase in SHP mRNA expression, followed by a decrease in insulin gene expression. Inhibition of endogenous SHP gene expression by small interfering RNA partially restored high-glucose–induced suppression of the insulin gene. Adenovirus-mediated overexpression of SHP in INS-1 cells impaired glucose-stimulated insulin secretion as well as insulin gene expression. SHP downregulates insulin gene expression via two mechanisms: by downregulating PDX-1 and MafA gene expression and by inhibiting p300-mediated pancreatic duodenal homeobox factor 1–and BETA2-dependent transcriptional activity from the insulin promoter. Finally, the pancreatic islets of diabetic OLETF rats express SHP mRNA at higher levels than the islets from LETO rats. These results collectively suggest that SHP plays an important role in the development of β-cell dysfunction induced by glucotoxicity.
- FBS, fetal bovine serum
- GSIS, glucose-stimulated insulin secretion
- KRBB, Krebs-Ringer bicarbonate buffer
- PDX, pancreatic duodenal homeobox factor
- SHP, small heterodimer partner
- siRNA, small interfering RNA
Footnotes
-
K.-G.P. and K.-M.L. contributed equally to this work.
Additional information for this article can be found in an online appendix at http://dx.doi.org/10.2337/db06-0753.
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
-
- Accepted October 19, 2006.
- Received June 2, 2006.
- DIABETES











